Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Due to pain being a complex, subjective phenomenon, defining pain has been a challenge. In medical diagnosis, pain is regarded as a symptom of an underlying condition.

Rilento is focused on developing acute pain management solutions that do not rely on addictive opioids, offering competitive performance without dangerous side-effects, improving pain management outcomes and quality of life for clinicians and patients who seek alternatives to opioids.

​

Rilento uses the biology of the healing process to inform the design and performance of tailored time release compositions that address the multi-factor contributions to acute pain. 

Rilento has developed a unique and efficient approach for rapid concept prototyping and testing to maximize fit-for-purpose formulations with broad clinician appeal:

Copyright © 2017-2018 Rilento Pharma, LLC

This website makes use of cookies. Please see our privacy policy for details.

OK